Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
出版年份 2019 全文链接
标题
Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
作者
关键词
-
出版物
BMC CANCER
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-01
DOI
10.1186/s12885-019-6221-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Overexpression of miR-182 inhibits ossification of ligamentum flavum cells by targeting NAMPT
- (2018) Qiang Zhang et al. EXPERIMENTAL CELL RESEARCH
- Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells
- (2018) Zahra Hesari et al. GENE
- Breast cancer diagnosis: Imaging techniques and biochemical markers
- (2018) Seyed Hamed Jafari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- miRNA-based strategy for modulation of influenza A virus infection
- (2018) Mohsen Keshavarz et al. Epigenomics
- microRNA-300/NAMPT regulates inflammatory responses through activation of AMPK/mTOR signaling pathway in neonatal sepsis
- (2018) Yexuzi Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast
- (2018) Semir Vranic et al. Clinical Breast Cancer
- Micro-RNAs as critical regulators of matrix metalloproteinases in cancer
- (2018) Somaye Noruzi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Inhibition of Nicotinamide Phosphoribosyltransferase Induces Apoptosis in Estrogen Receptor-Positive MCF-7 Breast Cancer Cells
- (2017) Mohammad Alaee et al. Journal of Breast Cancer
- Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells
- (2017) Zafar Gholinejad et al. PEPTIDES
- MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH
- (2017) Wenhui Qiao et al. Oncology Letters
- Extracellular nicotinamide phosphoribosyltransferase, a new cancermetabokine
- (2016) Ambra A Grolla et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer
- (2016) Huai-Qiang Ju et al. CANCER LETTERS
- Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance
- (2016) Lingling Wang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential
- (2015) Wei Wang et al. Journal of Zhejiang University-SCIENCE B
- NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer
- (2015) S M Hong et al. ONCOGENE
- miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor
- (2015) Xiaoli Pang et al. ONCOLOGY REPORTS
- miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo
- (2015) XINGYU LIN et al. ONCOLOGY REPORTS
- MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a
- (2015) HUI ZHOU et al. ONCOLOGY REPORTS
- Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
- (2015) Deepak Sampath et al. PHARMACOLOGY & THERAPEUTICS
- Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
- (2015) Nadia Sawicka-Gutaj et al. TUMOR BIOLOGY
- Decreased miR-154 expression and its clinical significance in human colorectal cancer
- (2015) Yang Kai et al. World Journal of Surgical Oncology
- MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2
- (2015) Yuan Yuan et al. PLoS One
- Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: Clinical impact of miR-363-3p
- (2014) Hyun Park et al. GYNECOLOGIC ONCOLOGY
- Expression of Nicotinamide Phosphoribosyltransferase-Influenced Genes Predicts Recurrence-Free Survival in Lung and Breast Cancers
- (2014) Tong Zhou et al. Scientific Reports
- Elevated microRNA-34a in obesity reduces NAD+levels and SIRT1 activity by directly targeting NAMPT
- (2013) Sung-E Choi et al. AGING CELL
- Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors
- (2013) C. C. S. Chini et al. CLINICAL CANCER RESEARCH
- miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2
- (2013) Chaoguang Xin et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Nicotinamide Phosphoribosyl Transferase (Nampt) Is a Target of MicroRNA-26b in Colorectal Cancer Cells
- (2013) Chenpeng Zhang et al. PLoS One
- Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation
- (2012) Xin-Yu Chen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome
- (2012) Caterina Mian et al. THYROID
- High Visfatin Expression in Breast Cancer Tissue Is Associated with Poor Survival
- (2011) Y.-C. Lee et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
- (2011) A. Menssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets
- (2010) Wenzhang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics
- (2010) K. E. Allen et al. MOLECULAR CANCER THERAPEUTICS
- Visfatin stimulates proliferation of MCF-7 human breast cancer cells
- (2010) Jae Geun Kim et al. MOLECULES AND CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation